However, further studies are needed to comprehend the abnormalities in the histone system that may result in NAFLD through PPARγ signaling, which would greatly increase our understanding of the pathophysiology of this condition. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.